ICAM-1 expression on neuro-vasculature was found to strongly correlate with relapses in RRMS patients, while the blood levels of its soluble form is associated with the degree of BBB impairment and disease activity in MS subjects (Cannella et al., 1990; Hartung et al., 1995). The gene discussed is ICAM1; the disease is myeloid sarcoma.